Iris Li

I founded New Frontier Enterprises to find, acquire and operate one exceptional business in the health care industry in the US.

At Believer Pharmaceuticals, we focus on the development of novel therapeutics targeting transcription factors for intractable solid tumors and blood cancers. Responsible for company operations, fundraising and advisory board selections.

Class of 2024

Performed deal evaluations on lower middle market PE deals proposed by search funds across the US.

Led healthcare equity deal opportunities of deal value ranging USD 20m-2bn across Asian region with support from juniors, including in-house research on industry & valuation, identifying key investment merits & risks, LBO financial modeling, conducting third party due diligence, hosting management meetings and drafting Investment Memo.

Responsible for go-to-market and business development of Corning's Emerging Innovations Group of products in Southeast Asia, including Advanced-Flow™ Reactors (AFR), Fibrance® Light-Diffusing Fiber, Gorilla® Glass, among others. Effort led to more than $2M new prospects in under 6 months.

Vertical focus on the LSHC industry, serving a diverse clientele including pharma, pharma associations, biotech, hospitals and clinic chains, covering Southeast Asia region. Directly reports to Deloitte Southeast Asia Health Care Sector Leader, while working cross-functional, cross-country with Deloitte Financial Advisory (M&A, Corporate Finance), Consulting across Southeast Asia. Works include market due diligence and market scan for LSHC clients, investment target search for PE houses, design of clinical research strategic roadmap for a SEA country, advocacy for pharmaceutical industry associations, market entry strategy, competitive intelligence and risk assessment. Cross-functional works include financial modeling/valuation for life sciences/ health care companies. Knowledge in pharmaceutical and biopharmaceutical manufacturing landscape, IVD market including molecular diagnostics and next-gen sequencing, digital health and tele-medicine, elderly care market. Member of Future Healthcare Centre of Excellence.

Analyst at EIU Healthcare (Clearstate), an EIU subsidiary focusing on custom healthcare market research. Specialise in market analysis and strategic consulting for healthcare industry, with a focus on emerging economies such as China, SEA, and Latin America.

A sub-committee under Biomedical Engineering Society Singapore

Trained in Good Clinical Practice and gained clear overview of how clinical trials are conducted in Singapore through training, shadowing experienced employees and preparing documents for Institutional Review Board/Ethics Committee applications for new clinical trials. Accumulated on-site experiences regarding how to work with doctors and study coordinators in hospitals by shadowing Clinical Research Associates for actual hospital site visits.

Full-ride scholarship for 4 years

One-semester exchange with Technical University of Munich.